QHSLab, Inc.

USAQ ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Operating Activities
Net Income $-2.9K $-18.5K $-86.6K $-82.4K $-106.7K $-192.6K $-216.2K $-310.1K
Depreciation & Amortization $18.0K $36.6K $73.9K $18.0K $18.0K $36.6K $73.9K $18.0K
Depreciation — — — — — — — —
Amortization $18.0K $18.0K — $18.0K $18.0K — — —
Stock-Based Compensation $0 $0 $0 $0 $0 $6.0K $6.2K $6.0K
Net Cash from Operating Activities $87.4K $56.6K $-135.2K $13.1K $-39.2K $1.7K $-69.8K $-183.1K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — $0 $0
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-50.1K $-41.2K $136.5K $-71.7K $55.0K $-87.3K $10.5K $323.9K
Net Change in Cash $37.3K $15.3K $1.3K $-58.6K $15.8K $-85.6K $-59.2K $140.8K
Free Cash Flow — — — — — — — —
← Newer Page 2 of 6 Older →